decentralized clinical trials Archives

Why CTMS Is Critical As Trial Complexities Increase

November 9, 2021

The clinical trials industry is buckling under the weight of continuously growing complexities. Developing an interconnected clinical trials ecosystem will be essential to minimizing the ripple effects of complexity impacting your sites and patients. As…

How to Sustain Clinical Trial Patient Engagement

September 7, 2021

The process of bringing a new treatment to market can be a long, arduous journey. On average, it takes ten years for a treatment to travel all the way from clinical trials to market approval.1…

How eSource Optimizes The Clinical Site Experience

September 7, 2021

Trial sites are a cornerstone of clinical research but are often overloaded with a myriad of complex, manual, and time-sensitive tasks. How can sites be expected to create a positive patient experience, ensure safety and…

The Power of Patient-Centricity in Rare Disease Studies

September 6, 2021

Orphan drug discoveries promise unprecedented opportunities, as well as challenges. Unfortunately, research in the rare disease space presents some of the highest hurdles in medicine due to the nature of their small, complex patient populations.…

4 Reasons Decentralized Trials Are Here to Stay

July 6, 2021

Long before the global pandemic, clinical trial sponsors were consumed with accelerating their studies and improving the trial experience for key stakeholders. Decentralization emerged as a leading factor in this pursuit. As COVID-19 inundated healthcare…

Thank Technology: Oncology’s Golden Age Is Here

March 20, 2021

To my mom, sister, father-in-law, and late aunt, I promise this: The 2020s will be a breakthrough decade for oncology. For me, cancer isn’t some abstract concept. Multiple members of my family are alive today…

How Decentralized Trials Strengthen Your Participation Pool

March 16, 2021

Long before COVID-19, recruiting and retaining patients for clinical trials was a growing problem with 85% of all trials failing to recruit enough patients and 80% delayed due to recruitment problems and high drop-out rates.…

Hesitant to Embrace Decentralized Trials Because of Regulations?

February 12, 2021

As the COVID-19 pandemic first entered the states, the U.S. Food and Drug Administration (FDA) quickly recognized that the public health emergency would disrupt the conduct of clinical trials for medical products. New challenges arose…

The Importance of Diversity in Clinical Trials

January 28, 2021

In the world of clinical trials, uniformity can be a dirty word. From blind use of placebos to dosage variation, incorporation of variables is an essential part of any study. But it’s important for…

The Future of Informed Consent

August 7, 2020

From eClinical data collection to telehealth to wearables and beyond, the clinical trials industry has seen a mass of technological advances over the past decade. Informed consent is critical to every clinical trial, but often…

Virtual, Decentralized, Hybrid: What’s the Difference?

August 3, 2020

The clinical trial landscape is ever-changing. New technology and innovation have changed the way we look at clinical trial design. While we can agree that the recent focus on patient-centricity has been a long time…

5 Essential Considerations for Global Clinical Trials

May 4, 2020

Over the past 10 years, the clinical trial industry has transformed dramatically. Globalization has taken off, giving rise to Contract Resource Organization (CRO) outsourcing, decentralized clinical trials, and overall greater transnational collaboration. Take a look…

decentralized clinical trials

Why CTMS Is Critical As Trial Complexities Increase

How to Sustain Clinical Trial Patient Engagement

How eSource Optimizes The Clinical Site Experience

The Power of Patient-Centricity in Rare Disease Studies

4 Reasons Decentralized Trials Are Here to Stay

Thank Technology: Oncology’s Golden Age Is Here

How Decentralized Trials Strengthen Your Participation Pool

Hesitant to Embrace Decentralized Trials Because of Regulations?

The Importance of Diversity in Clinical Trials

The Future of Informed Consent

Virtual, Decentralized, Hybrid: What’s the Difference?

5 Essential Considerations for Global Clinical Trials

COVID-19: The Catalyst for Change

How COVID-19 is Causing the Industry to Rethink Paper vs ePRO

Patient Diversity and eClinical Vendor Selection

Decentralized Trials: How Modern Tech Can Transform Your Trials

Decentralized Trials: How to Get Started

The Rise of Decentralized Trials

3 Ways Patient-Centricity Can Boost Clinical Trial ROI

3 Reasons Why eSource Is a Must for Global Trials

decentralized clinical trials

Enter a topic, term or keyword below:

Subscribe to our mailing list